Tavs Qvist1, Susan Alice Cowan, Christian Graugaard, Marie Helleberg. 1. From the *Department of Infectious Diseases, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark; †Department of Infectious Disease Epidemiology, Statens Serum Institut, Copenhagen, Denmark; and ‡Center for Sexology Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Abstract
INTRODUCTION: The aim of the study was to evaluate a community-based human immunodeficiency virus (HIV) testing program for its capacity to reach men who have sex with men (MSM) and successfully refer HIV-positive patients to treatment. METHODS: A walk-in clinic placed in the heart of the Copenhagen MSM community provided sexually transmitted infection counseling and rapid HIV testing. In addition, syphilis testing and hepatitis B vaccination were offered. The clinic was staffed with specially trained, predominantly non-health care personnel, and services were anonymous and free of charge. RESULTS: A total of 3012 HIV tests with concomitant counseling were performed between 2008 and 2012. The median age of users was 33 years (range, 16-73 years), 18% were non-Danish citizens, and 12% reported that this was their first HIV test. Thirty-eight individuals tested positive; however, 1 was found to be false positive by routine confirmatory testing. The remaining 37 users were true positive. All but 1 user was successfully linked to care at an infectious disease department and achieved full viral suppression after a median of 8 months (interquartile range, 5-19 months). The 37 positive patients accounted for 11% of all newly diagnosed HIV cases among MSM in Copenhagen in the period covered. Patients diagnosed in Checkpoint were younger than other newly diagnosed MSM, but had similar median CD4 counts at the time of diagnosis (420 [interquartile range, 260-590]). Seventy-six MSM (3%) were found syphilis positive in rapid testing and referred for confirmatory testing. Furthermore, 264 MSM completed a 3-shot hepatitis B vaccination program. CONCLUSIONS: Easily accessible, community walk-in clinics and targeted testing in high-risk settings are convenient for populations of MSM less likely to seek out the established health care system. Checkpoint diagnosed 37 new HIV cases, posed no barrier to successful linkage to care, was noninferior in quickly reducing community viral load, was cost-effective, reached younger MSM, and proved an ideal platform for trying out new interventions and test forms, which conventional health care providers have not yet embraced.
INTRODUCTION: The aim of the study was to evaluate a community-based human immunodeficiency virus (HIV) testing program for its capacity to reach men who have sex with men (MSM) and successfully refer HIV-positive patients to treatment. METHODS: A walk-in clinic placed in the heart of the Copenhagen MSM community provided sexually transmitted infection counseling and rapid HIV testing. In addition, syphilis testing and hepatitis B vaccination were offered. The clinic was staffed with specially trained, predominantly non-health care personnel, and services were anonymous and free of charge. RESULTS: A total of 3012 HIV tests with concomitant counseling were performed between 2008 and 2012. The median age of users was 33 years (range, 16-73 years), 18% were non-Danish citizens, and 12% reported that this was their first HIV test. Thirty-eight individuals tested positive; however, 1 was found to be false positive by routine confirmatory testing. The remaining 37 users were true positive. All but 1 user was successfully linked to care at an infectious disease department and achieved full viral suppression after a median of 8 months (interquartile range, 5-19 months). The 37 positive patients accounted for 11% of all newly diagnosed HIV cases among MSM in Copenhagen in the period covered. Patients diagnosed in Checkpoint were younger than other newly diagnosed MSM, but had similar median CD4 counts at the time of diagnosis (420 [interquartile range, 260-590]). Seventy-six MSM (3%) were found syphilis positive in rapid testing and referred for confirmatory testing. Furthermore, 264 MSM completed a 3-shot hepatitis B vaccination program. CONCLUSIONS: Easily accessible, community walk-in clinics and targeted testing in high-risk settings are convenient for populations of MSM less likely to seek out the established health care system. Checkpoint diagnosed 37 new HIV cases, posed no barrier to successful linkage to care, was noninferior in quickly reducing community viral load, was cost-effective, reached younger MSM, and proved an ideal platform for trying out new interventions and test forms, which conventional health care providers have not yet embraced.
Authors: Lai Sze Tso; John Best; Rachel Beanland; Meg Doherty; Mellanye Lackey; Qingyan Ma; Brian J Hall; Bin Yang; Joseph D Tucker Journal: AIDS Date: 2016-06-19 Impact factor: 4.177
Authors: Paula Meireles; Raquel Lucas; Ana Martins; Ana Cláudia Carvalho; Ricardo Fuertes; João Brito; Maria José Campos; Luís Mendão; Henrique Barros Journal: BMJ Open Date: 2015-05-12 Impact factor: 2.692
Authors: Nicolas Lorente; Laura Fernàndez-López; Ricardo Fuertes; Daniela Rojas Castro; François Pichon; Bojan Cigan; Sophocles Chanos; Paula Meireles; Raquel Lucas; Stéphane Morel; Per Slaaen Kaye; Cristina Agustí; Irena Klavs; Tom Platteau; Jordi Casabona Journal: BMJ Open Date: 2016-07-13 Impact factor: 2.692
Authors: Nitika Pant Pai; Tiago Chiavegatti; Rohit Vijh; Nicolaos Karatzas; Jana Daher; Megan Smallwood; Tom Wong; Nora Engel Journal: Point Care Date: 2017-11-14